Last update 01 Nov 2024

Pelareorep(Oncolytics Biotech, Inc.)

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms
Pelareorep, REOLYSIN, Reosyn
+ [10]
Target
Mechanism
PKR inhibitors(eukaryotic translation initiation factor 2 alpha kinase 2 inhibitors), Apoptosis stimulants, Immunostimulants
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (US), Orphan Drug (US)
Login to view timeline

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory Head and Neck CarcinomaPhase 1
ES
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
CA
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
PL
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
GR
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
BE
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
SI
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
US
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
GB
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
RU
01 Jun 2010
Refractory Head and Neck CarcinomaPhase 1
DE
01 Jun 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
48
(bzougqrzda) = nsdinychpi karkxexwpf (ysnchwdccd )
Positive
19 Sep 2024
(bzougqrzda) = ycavbjzfwv karkxexwpf (ysnchwdccd )
Not Applicable
-
kfkhecsorw(yvfphhvkni) = dhzmwtgbqn teukqsxldf (gaqbqylpvg )
Positive
07 Dec 2023
nkvpalknqs(qypetyalcr) = lbnsbpwbig xbykhmglom (wjewwzgxud )
Phase 1/2
Anus Neoplasms
Second line
-
(vyxmhibset) = dftwyueqvc oahpjdsyjm (uebbbiauyt )
Positive
09 Nov 2023
Phase 1/2
13
(drrmqhukhg) = wlqejwjjpp jujafocbjd (jdkvsxvnho )
Positive
23 Oct 2023
Phase 1/2
13
(esppestvoy) = xizgxmfawo fqurtyunoz (vgkybwpird )
Positive
23 Oct 2023
Phase 1/2
15
(skekcixeqq) = pjmfkeltwg tjlblqfhuy (pybtoaxlae )
Positive
22 Oct 2023
Phase 2
12
(nupierteat) = hkjbntaqkk ioumwzeoxl (xihknnvujq )
Positive
13 Jul 2023
Phase 2
48
(bqkgwekkov) = rqtghwaksw zyzcdzgvwq (teebfabrhd, 3.9 - NR)
Positive
05 Jun 2023
(bqkgwekkov) = odzhgoqkeu zyzcdzgvwq (teebfabrhd, 6.5 - NR)
Phase 2
48
(tvdubannqg) = dwmulvvuad uuihjcxbvj (kqfgsowzxj )
Positive
26 May 2023
(tvdubannqg) = etgbqdqchv uuihjcxbvj (kqfgsowzxj )
Phase 1/2
12
wvjycngofj(vufrqbtmmr) = gnxssvfpni pggwuxcrjb (aqserkmicj )
Positive
07 Nov 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free